S2Medical AB

S2M · Nasdaq Stockholm · Healthcare

0.00SEK −33.3%last day

Price as of 2 October 2026

The price over the past year, with dividends: −59.1%

Performance

1 month

−35.7%

1 year

−59.1%

3 years, per year

−39.2%

5 years, per year

−67.1%

Largest fall, 3 years

−99.3%

Below the peak now

−100.0%

Volatility, 1 year

165.0%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.3

Dividend yield

0.0%

Return on equity

−100.1%

Net margin

−62.1%

Market value

0 m USD

Quality, value and trend

Where S2Medical stands against every Nordic stock today. 100 is best.

Quality37

Profitability and a sound balance sheet over time. Better than 37% of Nordic stocks.

Value100

The price measured against earnings, assets and cash flow. Better than 100% of Nordic stocks.

Trend44

The price development over the past year. Better than 44% of Nordic stocks.

Combined67

Quality, value and trend together. Better than 67% of Nordic stocks.

About S2Medical

S2Medical AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 10 employees.

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis